Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs

Background: Metformin use reportedly reduces cancer risk and improves survival in lung cancer patients. This study aimed to investigate the effect of metformin use in patients with diabetes mellitus (DM) and lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Integr Cancer Ther
Autors principals: Hung, Ming-Szu, Chuang, Min-Chun, Chen, Yi-Chuan, Lee, Chuan-Pin, Yang, Tsung-Ming, Chen, Pau-Chung, Tsai, Ying-Huang, Yang, Yao-Hsu
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6696848/
https://ncbi.nlm.nih.gov/pubmed/31409137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735419869491
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars